| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |